Volex plc (LSE:VLX) has spent recent years as an AIM-quoted cable and connector maker known chiefly to small-cap specialists. That may be changing. On 24 July 2026 the company moved to the Main Market of the London Stock Exchange, and on 25 August 2026 it told its AGM that Revenue in the first four months of the financial year had grown 28% organically, with full-year underlying operating profit now expected to beat market expectations.
Behind the numbers is a Business that has become a significant supplier of power and data connectivity hardware to data centres, alongside older franchises in off-highway vehicles, consumer electricals, medical equipment and electric vehicle charging. The question is whether a company valued at close to £1bn, and now visible to a wider pool of institutional buyers, still qualifies as under the radar.
AGM statement: 28% organic growth and guidance raised
The 25 August 2026 AGM statement covered the four months to 31 July 2026. Volex reported constant-currency organic revenue growth of 28.0% year on year, with all five end-markets expanding. Complex Industrial Technology, which houses the data centre business, led the way as customer Demand held at the elevated exit rate seen at the end of FY2026.
Management cautioned that the headline rate flatters the picture, because prior-year comparatives were depressed while data centre programmes were still ramping up. It pointed instead to sequential momentum, with monthly revenue averaging around 8% above the second-half FY2026 run rate. The board nonetheless said it expects FY2027 underlying operating profit to be ahead of current market expectations, citing operating leverage. The statement recorded company-compiled consensus, as of 24 August 2026, of $1,338m revenue and $138.3m underlying operating profit, a floor against which to judge the upgrade.
Two other developments framed the statement. On 14 July 2026 Volex agreed to buy the 64.3% of Kepler SignalTek it did not already own for up to $89.4m, including $74.7m in initial cash and up to $14.7m deferred against revenue targets. KST, which makes patient-connected medical cables and devices in China and Indonesia, generated $51.8m of revenue in the year to 31 March 2026 at an EBIT Margin above Volex's own. To fund the deal, Volex halved its share buyback from £40m to £20m, saying its Acquisition pipeline remains active.
What Volex does
Volex describes itself as a critical Manufacturing partner to category leaders, delivering complex power and data connectivity systems. It reports across five end-markets: Complex Industrial Technology (including data centres), Off-Highway (wiring harnesses for agricultural, construction and defence vehicles), Consumer Electricals (power cords), Medical (cabling for diagnostic and imaging equipment) and EV & Electrification (charging cables and connectors).
The group operates from 23 manufacturing sites. In FY2026 North America was the largest region at $645.5m of revenue, followed by Europe at $439.1m and Asia at $158.0m. The acquisition of Turkish harness maker Murat Ticaret expanded Off-Highway considerably. Volex reports in US dollars, though its shares, dividends and buyback are in sterling.
FY2026 results: revenue up 14%, margin above 10%
Preliminary results for the 52 weeks to 31 March 2026, published on 25 June 2026, showed revenue of $1,242.6m, up 14.4% on FY2025, with organic growth of 14.2%. Underlying operating profit rose 19.9% to $127.3m, lifting the underlying margin to 10.2% from 9.8%. Statutory operating profit climbed 46.0% to $121.0m.
Underlying profit before tax was $108.4m, up 23.7%, and statutory profit before tax $93.4m, up 45.3%. Underlying Basic Earnings Per Share rose 19.8% to 43.5 cents; statutory basic EPS was 35.2 cents. The full-year Dividend was raised 6.7% to 4.8 pence per share, comprising a 1.6p interim and a 3.2p final.
The divisional picture was uneven. Complex Industrial Technology revenue jumped 56.3% organically to $382.9m, with data centre revenue roughly doubling to 63% of the division, close to a fifth of group sales. Off-Highway grew 20.0% organically to $279.3m and EV & Electrification 4.8% to $181.8m. Consumer Electricals fell 7.8% to $242.4m and Medical declined 10.5% to $156.2m.
Underlying free Cash Flow was flat at $42.3m, with cash conversion of 63.9% reflecting Working Capital Investment and Capital Expenditure of $34.8m. Net Debt before leases fell to $121.5m from $127.4m, taking covenant leverage down to 0.8 times. Mr Rothschild said Volex had delivered its five-year plan a year early and that its manufacturing transfer capability had been "a particular strength" as customers responded to Tariff changes.
What could drive the stock next?
The most immediate catalyst is quantifying the upgrade. Volex has said FY2027 underlying operating profit will exceed the $138.3m consensus but has not put a number on it; a half-year trading update, which last year came in mid-October, and interim results in November should narrow the range.
Data centre demand remains the swing factor. Management set new medium-term targets at its 22 April 2026 Capital Markets event: $2bn of revenue, comprising roughly $500m of organic growth and around $300m from acquisitions, a 12% underlying Operating Margin and ROCE of at least 20%. KST is the first step on that acquisition path; further bolt-ons, the £20m buyback with shares cancelled, and a wider investor audience after the Main Market move could all keep the shares in focus.
Risks investors should watch
End-market concentration is the obvious one. Data centre revenue roughly doubled in FY2026 to close to a fifth of the group, so any pause in data centre capital spending or a shift in supplier allocations would be felt quickly. Management's own warning that the 28% growth rate will normalise against tougher comparatives is worth heeding.
Trade policy is a second risk. Volex manufactures in China, Indonesia, Turkey and elsewhere and says it has so far passed tariff costs to customers, but further changes could disrupt Supply chains or squeeze margins. Currency is another: a strong pound reduces the sterling value of dollar earnings, while the Turkish lira and euro affect labour costs. Cash conversion of 63.9% in FY2026 was below the prior year, and working capital, capex and acquisition spending will keep testing the balance sheet. Consumer Electricals and Medical both shrank last year, and KST adds integration risk in a segment that has been struggling.
Outlook
Volex enters the autumn with an upgraded profit outlook, a fresh Main Market listing and a strategy built around data centres, electrification and medical technology. The half-year trading update and November interims will show whether the 8% sequential revenue uplift is being sustained and how much growth is converting into cash. Investors will also watch the £20m buyback, the integration of KST and any further acquisitions towards the $2bn ambition. With the shares at around 540p in late August 2026 and a Market Value near £985m, whether Volex is still a sleeper is debatable; that more investors can now access it is not.




_11_18_2026_14_55_02_703826.jpg)

Please wait processing your request...